Skip to Main Content

Favorite Table | Download (.pdf) | Print
ACE Accelerate, Coordinate, Evaluate
ACTH Adrenocorticotropic hormone
AKI Acute kidney injury
ALK Anaplastic lymphoma kinase
ALP Alkaline phosphatase
ALT Alanine aminotransferase
AMU Acute medical unit
AOHC Acute oncology ‘hot clinic’
ASTCT American Society for Transplantation and Cellular Therapy
ATP Adenosine triphosphate
BRAF Serine/threonine-protein kinase B-Raf
BSA Body surface area
CAR Chimeric antigen receptor
CAT Cancer-associated thrombosis
CK Cytokeratin
CKD Chronic kidney disease
COPD Chronic obstructive pulmonary disease
CRC Colorectal cancer
CRMP5 Collapsing response mediator protein 5
CRP C-reactive protein
CRS Cytokine release syndrome
CSF Cerebrospinal fluid
CTCAE Common Terminology Criteria for Adverse Events
CTLA-4 Cytotoxic T lymphocyte-associated protein 4
CUP Carcinoma of unknown primary
DOAC Direct oral anticoagulant
DPD Dihydropyrimidine dehydrogenase
EGFR Epidermal growth factor receptor
eGFR Estimated glomerular filtration rate
ER Oestrogen receptor
FSH Follicle-stimulating hormone
5-FU Fluorouracil
G6PDD Glucose-6-phosphate dehydrogenase deficiency
GCSF Granulocyte colony-stimulating factor
GFR Glomerular filtration rate
GIST Gastrointestinal stromal tumour
GLP-1 Glucagon-like peptide 1
HBcAb Hepatitis B core antibody
HBeAg Hepatitis B virus e antigen
HBsAg Hepatitis B virus surface antigen
HBV Hepatitis B virus
HER2 Human epidermal growth factor receptor 2
HFS Hand–foot syndrome
HLH Haemophagocytic lymphohistiocytosis
HVS Hyperviscosity syndrome
ICANS Immune effector cell-associated neurotoxicity syndrome
ICE Immune effector cell-associated encephalopathy
ICPI Immune checkpoint inhibitor
IgA Immunoglobulin A
IGF-1 Insulin-like growth factor 1
IgG Immunoglobulin G
IgM Immunoglobulin M
IL-6 Interleukin-6
irAE Immune-related adverse event
IVAC Ifosfamide, etoposide, cytarabine
LDH Lactate dehydrogenase
LH Luteinizing hormone
LMWH Low-molecular-weight heparin
LVEF Left ventricular ejection fraction
MAS Macrophage activation syndrome
MASCC Multinational Association for Supportive Care in Cancer
MDC Multidisciplinary diagnostic centre
MDT Multidisciplinary team
MPE Malignant pericardial effusion
MRC Medical Research Council
MSCC Metastatic spinal cord compression
MUO Malignancy of unknown origin
NEWS2 Revised National Early Warning Score
PCN Percutaneous nephrostomy
PD-1 Programmed cell death protein 1
PDGF Platelet-derived growth factor
PD-L1 Programmed death-ligand 1
PFT Pulmonary function test
PR Progesterone receptor
PRES Posterior reversible encephalopathy syndrome
PSA Prostate-specific antigen
PTHrP Parathyroid hormone-related protein
RANK Receptor activator of nuclear factor kappa-B
RANKL Receptor activator of nuclear factor kappa-B ligand
R-CODOX-M Cyclophosphamide, vincristine, doxorubicin, methotrexate, cytarabine, rituximab
RILI Radiation-induced lung injury
RPA Recursive partitioning analysis
RTOG Radiation Therapy Oncology Group
SACT Systemic anticancer therapy
SCLC Small cell lung cancer
SGLT2 Sodium–glucose co-transporter 2
SIAD Syndrome of inappropriate antidiuresis
SRS Stereotactic radiosurgery
SVCO Superior vena cava obstruction
TKI Tyrosine kinase inhibitor
TLS Tumour lysis syndrome
TPE Therapeutic plasma exchange
TSH Thyroid-stimulating hormone
TTF Thyroid transcription factor
UGI Upper gastrointestinal
UKONS UK Oncology Nursing Society
VEGF Vascular endothelial growth factor
VEGFR Vascular endothelial growth factor receptor
VTE Venous thromboembolism
WBC White blood cell count
WBRT Whole brain radiotherapy
WTE Working time equivalent

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.